Biocryst Pharmaceuticals reported $-164215000 in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
DBV Technologies DBVT:US 82.06M 17.21M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Biocryst Pharmaceuticals BCRX:US $ -164.22M 57.23M
Chemocentryx CCXI:US $ 258.72M 27.4M
Chugai Pharma 4519:JP Y 1240510M 52493M
Daiichi Sankyo 4568:JP Y 1350872M 19652M
Enanta Pharmaceuticals ENTA:US $ 358.58M 25.8M
Gilead Sciences GILD:US $ 19927M 1142M
GlaxoSmithKline GSK:LN 16181M 1126M
Glaxosmithkline GSK:US $ 16181M 1126M
Intra Cellular Therapies ITCI:US $ 792.75M 374.86M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Karyopharm Therapeutics KPTI:US $ -83079000 3.41M
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Neurocrine Biosciences NBIX:US $ 1391.1M 17.1M
Novavax NVAX:US $ 65.32M 417M
Ptc Therapeutics PTCT:US $ -90.58M 92.02M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M
Sarepta Therapeutics SRPT:US $ 856.89M 71.12M
Ultragenyx Pharmaceutical RARE:US $ 796.42M 126.14M
Vertex Pharmaceuticals VRTX:US $ 10907M 807M
YTE INCY:US $ 3863.07M 93.07M